文献速递衰弱、肌少症与跌倒老年综合评估

衰弱识别的不一致性:超越预测效度

Discrepancy in Frailty Identification: Move Beyond Predictive Validity.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

本研究基于美国四个社区65岁及以上老年人(n=5,362)的前瞻性观察数据,比较衰弱指数(FI)与身体衰弱表型(PFP)在个体层面分类的一致性。结果显示两种工具衰弱患病率相近(PFP 7.0%,FI 8.3%),但仅12%的个体分类一致,提示PFP与FI在临床中不可互换使用。

要点

  • PFP与FI的衰弱患病率相近,但个体层面分类一致性仅12%。
  • 48%的衰弱者仅由FI识别,39%仅由PFP识别,分类差异显著。
  • PFP测量的衰弱与年龄和死亡率的关联强于FI。

核心结论

  • 尽管PFP与FI的衰弱患病率相当,但个体层面分类存在实质不一致,最高一致性仅见于最脆弱亚组。
  • PFP与FI在临床重要情境中不能互换使用。

研究设计与样本

  • 前瞻性观察研究,从美国四个社区Medicare合格名单中选取65岁及以上老年人,样本量n=5,362。
  • PFP采用心血管健康研究PFP测量,满足5条标准中3条及以上定义为衰弱。
  • FI基于48项预先选定指标的缺陷比例计算,FI大于0.35定义为衰弱。

主要发现

  • 衰弱患病率:PFP为7.0%,FI为8.3%。
  • 由任一工具判定为衰弱的730人中,仅12%两种工具一致。
  • 39%仅由PFP判定为衰弱而FI未判定,48%仅由FI判定为衰弱而PFP未判定。
  • 65-72岁或疾病负担较大的参与者更可能被FI判定为衰弱而PFP未判定。
  • PFP测量的衰弱与年龄和死亡率的关联强于FI。

关键数值与推荐

  • PFP衰弱判定:满足5条标准中3条及以上。
  • FI衰弱判定:FI大于0.35。
  • FI基于48项预先选定指标的缺陷比例计算。

临床怎么用

  • 临床中不应将PFP与FI的衰弱判定结果直接互换,需注意两者分类不一致的风险。
  • 对65-72岁或疾病负担较大的老年人,FI可能更易判定为衰弱而PFP未判定,应结合临床情境解读。
  • 若关注与年龄和死亡率的关联,PFP测量的衰弱关联更强,可优先考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the discordance in frailty classification between the frailty index (FI) and the physical frailty phenotype (PFP) and identify factors discriminating those with discordant frailty classification from each other and from those for whom the assessments agree. METHODS: A prospective observational study of older adults aged 65 and older selected from Medicare eligibility lists in four U.S. communities (n = 5,362). The PFP was measured by the Cardiovascular Health Study PFP. Participants meeting three or more of the five criteria were deemed frail. The FI was calculated as the proportion of deficits in an a priori selected set of 48 measures, and participants were classified as frail if FI is greater than 0.35. RESULTS: The prevalence of frailty was 7.0% by the PFP and 8.3% by the FI. Of the 730 deemed frail by either instrument, only 12% were in agreement, whereas 39% were classified as frail by the PFP, but not the FI, and 48% were classified as frail by the FI, but not the PFP. Participants aged 65-72 years or with greater disease burden were most likely to be characterized as being FI-frail, but not PFP-frail. The associations of frailty with age and mortality were stronger when frailty was measured by the PFP rather than the FI. CONCLUSIONS: Despite comparable frailty prevalence between the PFP and the FI, there was substantial discordance in individual-level classification, with highest agreement existing only in the most vulnerable subset. These findings suggest that there are clinically important contexts in which the PFP and the FI cannot be used interchangeably.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Xue QL, Tian J, Walston JD, et al. Discrepancy in Frailty Identification: Move Beyond Predictive Validity. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30789645. doi:10.1093/gerona/glz052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。